New genetic risk factors for depression identified across global populations

New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.

PE Firm Thoma Bravo Makes Strategic Investment in Bluesight & Medacist Acquisition

What You Should Know: – Today Thoma Bravo, a private equity software investment firm, announced a strategic growth investment in Bluesight, the Medication Intelligence™ Company.

July 17, 2023

Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19 – Psychedelic Alpha

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused

July 10, 2023

Fountain Life Acquires LifeOmic to Optimize Preventative Care

What You Should Know: – Fountain Life, a leader in advanced diagnostics and preventative healthcare, has acquired LifeOmic, a health data technology company specializing in

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.